Cctu

This study is testing if adding a more intensive chemotherapy combination (called FOLFOXIRI) to the standard pre-surgery treatment can better shrink aggressive rectal tumors. It involves 72 adults with high-risk, locally advanced rectal cancer that hasn't spread to distant organs…

This study tests the immunotherapy drug pembrolizumab in 30 patients with advanced liver cancer caused by chronic hepatitis B infection. Researchers will give the drug every three weeks and take tumor samples before and during treatment to study how the immune system responds. Th…

This study compares two different radiation treatment schedules for men with high-risk prostate cancer that hasn't spread. All participants receive hormone therapy plus radiation, but one group gets 5 weekly treatments while the other gets 38 daily treatments. The main goal is to…